SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in February:
Read more at globenewswire.comORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC PHARMACEUTICALS INC
NASDAQ:ORIC (2/11/2025, 8:00:01 PM)
After market: 9.9 +0.05 (+0.51%)9.85
-1.38 (-12.29%)
ORIC Latest News and Analysis
13 hours ago - ChartmillTuesday's session: gap up and gap down stocksLet's have a look at the gap up and gap down stocks in today's session.
